14 Nov, EOD - Indian

SENSEX 77580.31 (-0.14)

Nifty 50 23532.7 (-0.11)

Nifty Bank 50179.55 (0.18)

Nifty IT 42390.85 (0.05)

Nifty Midcap 100 54043.1 (0.45)

Nifty Next 50 67408.65 (0.46)

Nifty Pharma 21752 (-0.26)

Nifty Smallcap 100 17601.05 (0.81)

14 Nov, EOD - Global

NIKKEI 225 38305.85 (-0.87)

HANG SENG 19743.89 (1.63)

S&P 5922 (0.23)

Login/Signup
LOGIN HERE
Cancel

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : | NSE Symbol : | ISIN : | Industry : |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
03-Oct-2024 07-Oct-2024 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2024 inter alia to consider and approve Please find enclosed herewith the Intimation of Board meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations2015 Please find enclosed herewith Outcome of Board Meeting Pusuant to regulation 30 of Sebi ( LODR)Regulation ,2015 held on today i.e. 07th October 2024 (As per BSE Announcement Dated on 07/10/2024)
06-Sep-2024 05-Sep-2024 AGM Outcome of Board Meeting held on September 05, 2024
23-Jul-2024 29-Jul-2024 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve Intimation regarding Holding of Board Meeting on 29th July 2024 to consider Un-Audited Financial Results for the quarter ended June 30 2024 Please find enclosed herewith the Un- Audited Standalone financial result for the quarter ended on June 30,2024 . To Considered and approved the standalone Un-Audited financial results of the Company for the quarter ended 30th June, 2024. A copy of the said standalone Un-audited financial results along with the Limited review report from statuary auditor is enclosed herewith (As Per BSE Announcement Dated on: 29/07/2024)
03-May-2024 09-May-2024 Accounts Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 inter alia to consider and approve The Boad meeting of the company will be held Thursday 09th May 2024 Outcome of the Board Meeting is enclosed. (As per BSE Announcement Dated on 09/05/2024)
03-Feb-2024 14-Feb-2024 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December 2023 Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2023 (As Per BSE Announcement dated 10.02.2024) Outcome of Board Meeting and Un-Audited Financial Results for the quarter and nine months ended 31st December, 2023 Results - Financial Results for 31.12.2023 Change in Corporate Office Address Change in Directorate Change in Management (As Per BSE Announcement Dated on 14/02/2024)
02-Nov-2023 14-Nov-2023 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Un-Audited Financial Results for the quarter and six months ended September 30 2023 Board Meeting Intimation for Rescheduling Of Board Meeting On 14Th November, 2023 Instead Of 08Th November, 2023 To Consider Un-Audited Financial Results For The Quarter And Six Months Ended September 30, 2023 BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the Un-Audited Financial Results for the quarter and six months ended September 30, 2023 (As Per BSE Announcement Dated on 08.11.2023) Outcomes of Board Meeting and Un-Audited Financial Results (Standalone) for the Quarter and Six Months ended 30th September, 2023 Reconstitution of Committees (As Per BSE Announcement Dated on 14.11.2023)
04-Sep-2023 04-Sep-2023 AGM Outcome of Board Meeting
08-Aug-2023 14-Aug-2023 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve the Un-Audited Financial Results for the quarter ended 30th June 2023 Outcomes of Board Meeting and Un-Audited Financial Results (Standalone) for the Quarter and Three Months ended 30th June, 2023 Financial Results for the quarter and three months ended 30.06.2023 Intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 14.08.2023)
30-Jun-2023 30-Jun-2023 Change in Directors Outcome of Board Meeting Change in Management Change in Directorate Resignation of Directors Appointment of Chief Financial Officer
23-May-2023 29-May-2023 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve the Audited Financial Results for the quarter and year ended March 31 2023 Outcomes of Board Meeting and Audited Financial Results (Standalone) for the Quarter and Year ended 31st March, 2023 (As Per BSE Announcement Dated on 29.05.2023)
31-Mar-2023 31-Mar-2023 Change in Directors Outcome of Board Meeting Appointment of Company Secretary and Compliance Officer Change in Management Reconstitution of the Committees Resignation of Chief Financial Officer Resignation of Directors
02-Feb-2023 10-Feb-2023 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December 2022 Outcomes of Board Meeting and Un-Audited Financial Results for the quarter ended 31.12.2022 and year to date from 01.04.2022 to 31.12. 2022 Un-Audited Financial Results for the quarter ended 31.12.2022 and year to date from 01.04.2022 to 31.12. 2022 Intimation of Appointments Appointment of Internal Auditors of the Company (As per BSE Announcement Dated on 10/02/2023)
26-Nov-2022 26-Nov-2022 Change in Directors Outcomes of Board Meeting held on 26th November, 2022
04-Nov-2022 12-Nov-2022 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve Un-Audited Financial Results for the quarter and six months ended September 30 2022 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) of the Company for the Quarter ended 30.09.2022 and year to date from 01.04.2022 to 30.09.2022 as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal. (As Per BSE Announcement Dated 12.11.2022) Submission of Newspaper Advertisements of the Extract of Un-Audited Financial Results approved in Board Meeting of the Company held on 12.11.2022 (As Per BSE Announcement Dated on 14.11.2022)
14-Jul-2022 20-Jul-2022 Quarterly Results Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2022 inter alia to consider and approve Un-Audited Financial Results for the quarter and three months ended June 30 2022 . Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and three months ended 30th June, 2022 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and three months ended 30th June, 2022 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal. (As Per BSE Announcement Dated on 20.07.2022)
1 2 3